英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
desprecio查看　desprecio　在百度字典中的解释百度英翻中〔查看〕
desprecio查看　desprecio　在Google字典中的解释Google英翻中〔查看〕
desprecio查看　desprecio　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • CureVac CEO Alexander Zehnder Acquires Common Shares of Company Stock
    mous potential of our proprietary mRNA technology,” said Dr Alexander Zehnder, Chief Executive Officer of CureVac “We are b ilding a strong clinical pipeline for prophylactic vaccines and are increasing our footprint in cancer immunotherapy My purchase shows my continued commitment to the company and confidence in the value of our
  • CureVac - Wikipedia
    On 11 March 2020, it was reported that CureVac AG's CEO Daniel Menichella was no longer the company's CEO, having been replaced by the company founder Ingmar Hoerr
  • BioNTech Announces Strategic Transaction to Acquire CureVac in Public . . .
    “To me, this transaction is more than a business decision, it represents a shared commitment to leverage the full potential of mRNA as a disruptive technology to develop transformative therapies with greater scale and speed,” said Dr Alexander Zehnder, CEO of CureVac
  • A New Chapter Begins Today marks a truly exciting and . . . - LinkedIn
    Alexander Zehnder, MD, MBA Zehnder, CEO of CureVac: “To me, this transaction is more than a business decision, it represents a shared commitment to leverage the full potential of mRNA as a
  • Alexander Zehnder - CEO at CureVac | The Org
    Alexander Zehnder, MD, MBA, currently serves as the Chief Executive Officer of CureVac since April 2023
  • CureVac N. V. . (1 17 24). Press Release: CureVac CEO Alexander Zehnder . . .
    CureVac N V (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced that its Chief Executive Officer, Alexander Zehnder, recently purchased 50,000 common shares of CureVac stock
  • CureVac Appoints Alexander Zehnder as CEO From April 1, 2023
    CureVac (Nasdaq: CVAC) is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing, optimizing, and manufacturing this versatile biological molecule for medical purposes
  • CureVac–Zehnder A: management, 202304– CEO before Sanofi + Roche . . .
    CureVac (Nasdaq: CVAC) is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing, optimizing, and manufacturing this versatile biological molecule for medical purposes
  • CureVac Management
    Dr Alexander Zehnder, M D, MBA, is Chief Executive Officer at CureVac N V since April 01, 2023 and is its Managing Director since March 2023 and serves as its Member of Management Board since 2023
  • CureVac Appoints Alexander Zehnder as CEO From April 1, 2023
    With our recently reported platform validation we are entering a new chapter in CureVac’s development, which marks a natural transition for me CureVac is stronger than ever as I hand over to Alexander Zehnder His expertise will add a lot to shape the future success of CureVac ”





中文字典-英文字典  2005-2009